Lianluo Smart (LLIT)

Executive Summary

Lianluo Smart Limited, together with its subsidiaries, designs, develops, markets, and distributes medical products and medical components primarily in China and internationally. More Details


Earnings have grown 9.3% per year over the past 5 years

Risk Analysis

Highly volatile share price over the past 3 months

Shareholders have been substantially diluted in the past year

Makes less than USD$1m in revenue ($480K)

Does not have a meaningful market cap ($18M)

Snowflake Analysis

Adequate balance sheet and overvalued.

Similar Companies

Search for a company to compare.